(VIANEWS) – Shares of Catalyst Pharmaceuticals (NASDAQ Composite: CPRX) jumped 5.88% to $7.11 at 10:24 EST on Friday, after four successive sessions in a row of gains. NASDAQ Composite is dropping 0.77% to $15,063.02, after five sequential sessions in a row of losses. This seems, up until now, a somewhat down trend exchanging session today.

Catalyst Pharmaceuticals’s last close was $6.72, 11.35% below its 52-week high of $7.58.


Today’s last reported volume for Catalyst Pharmaceuticals is 292472 which is 68.56% below its average volume of 930457.

Catalyst Pharmaceuticals’s Sales

Catalyst Pharmaceuticals’s sales growth is 18% for the ongoing quarter and 15.6% for the next.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth grew by 22.8%, now sitting on 126.9M for the twelve trailing months.


Catalyst Pharmaceuticals’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.27%, a negative 1.12%, and a positive 2.44%, respectively.

Catalyst Pharmaceuticals’s highest amplitude of average volatility was 2.27% (last week), 2.08% (last month), and 2.44% (last quarter), respectively.

Catalyst Pharmaceuticals’s Stock Yearly Top and Bottom Value

Catalyst Pharmaceuticals’s stock is valued at $7.11 at 10:24 EST, below its 52-week high of $7.58 and way higher than its 52-week low of $3.27.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s worth is above its 50-day moving average of $6.53 and way above its 200-day moving average of $5.51.

More news about Catalyst Pharmaceuticals (CPRX).


Please enter your comment!
Please enter your name here